Literature DB >> 10206263

Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.

M A Rodríguez-Pérez1, R Danis-Lozano, M H Rodríguez, J E Bradley.   

Abstract

OBJECTIVE AND
METHOD: To compare the utility of an ELISA using 3 recombinant antigens with that of the skin biopsy to estimate incidence of infections in a sentinel cohort of individuals living in an endemic community in southern Mexico during a set of 11 subsequent ivermectin treatments.
RESULTS: The apparent community prevalence of infection and microfilarial skin infection before and after 11 treatments with ivermectin plus nodulectomy were 78% and 13%, and 0.68 mf/mg and 0.04 mf/mg, respectively, as measured by skin biopsy. Of a group of 286 individuals participating in all surveys, a sentinel cohort of 42 mf and serologically negative individuals had been followed since 1994. The annual percentage of individuals becoming positive in this cohort was 24% (10/42), 28% (9/33), 0%, and 4.3% (1/23) in 1995, 1996, 1997 and 1998, respectively. Likewise, the incidence in children 5 years and under (n = 13) within this sentinel cohort was 15% (2/13), 18% (2/11), 0% and 11% (1/9), respectively. All individuals became positive to both tests simultaneously, indicating that seroconversion assessed infection incidence as accurately as skin biopsy in the sentinel group.
CONCLUSION: Incidence monitoring of a sentinel cohort provides an estimation of the parasite transmission in the community; it is less costly than massive sampling, and a finger prick blood test might be more acceptable in some communities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206263     DOI: 10.1046/j.1365-3156.1999.00363.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  7 in total

1.  Interruption of transmission of Onchocerca volvulus in the Oaxaca focus, Mexico.

Authors:  Mario A Rodríguez-Pérez; Thomas R Unnasch; Alfredo Domínguez-Vázquez; Alba L Morales-Castro; Graciela P Peña-Flores; María E Orozco-Algarra; Juan I Arredondo-Jiménez; Frank Richards; Miguel A Vásquez-Rodríguez; Vidal García Rendón
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.

Authors:  Alberto Gómez-Priego; Raymundo Mendoza; Jorge-Luis de-la-Rosa
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Detection of Onchocerca volvulus in Latin American black flies for pool screening PCR using high-throughput automated DNA isolation for transmission surveillance.

Authors:  Mario A Rodríguez-Pérez; Hemavathi Gopal; Monsuru Adebayo Adeleke; Erick Jesús De Luna-Santillana; J Natividad Gurrola-Reyes; Xianwu Guo
Journal:  Parasitol Res       Date:  2013-09-13       Impact factor: 2.289

4.  Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterising the community burden of Onchocerciasis.

Authors:  Joseph Pryce; Thomas R Unnasch; Lisa J Reimer
Journal:  PLoS Negl Trop Dis       Date:  2021-10-12

5.  Contribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico.

Authors:  Mario A Rodríguez-Pérez; Aldo Segura Cabrera; Cristian Lizarazo Ortega; María-Gloria Basáñez; John B Davies
Journal:  Filaria J       Date:  2007-12-18

6.  Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence.

Authors:  Charles H Washington; Jeanne Radday; Thomas G Streit; Heather A Boyd; Michael J Beach; David G Addiss; Rodrigue Lovince; Maribeth C Lovegrove; Jack G Lafontant; Patrick J Lammie; Allen W Hightower
Journal:  Filaria J       Date:  2004-05-05

7.  Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial.

Authors:  Patrick J Lammie; Gary Weil; Rahmah Noordin; Perumal Kaliraj; Cathy Steel; David Goodman; Vijaya B Lakshmikanthan; Eric Ottesen
Journal:  Filaria J       Date:  2004-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.